Ventricular
Tacharrhythmias
Ventricular tachyarrhythmias are potentially the most dangerous
cardiac arrhythmias, often requiring the most aggressive therapy.
However, there are some uncommon forms of ventricular tachycardia
that are relatively benign and often easily treated by mild medications
or even potentially curable using radiofrequency
catheter ablation. A common classification for ventricular tachyarrhythmias
is presented below:
In general ventricular
tacharrhythmias are classified in two ways: 1) by the appearance
of the QRS waves on the ECG recording or,
2) by their prognosis and life-threatening potential, which in turn,
is directly related to the degree of the patient's underlying heart
disease.
When viewed
in any of the recorded 12 ECG leads, monomorphic ventricular
tachycardia will exhibit QRS complexes that are identical in
size and shape and are unchanging (Figure 1). In technical terms,
a cardiac electrophysiologist would say that monomorphic ventricular
tachycardia has an unchanging QRS morphology and QRS axis.
These ECG findings contrast with those observed during polymorphic
ventricular tachycardia (Figure 2), in which the QRS size and
shape can change from beat-to-beat, even when viewed using the same
ECG lead. Ventricular fibrillation exhibits even more disorganized
and chaotic QRS waves when recorded by the 12-lead ECG machine (Figure
3).
In all patients,
a finding of polymorphic ventricular tachycardia or ventricular fibrillation triggers an aggressive
investigation of the cause(s) and administration of a definitive
treatment after completion of diagnostic studies. Polymorphic ventricular
tachycardia and ventricular fibrillation may occur in the setting
of an acute "heart attack" (myocardial infarction), or
may occur without warning in patients with a history of chronic
underlying severe heart disease such as cardiomyopathy coronary
artery disease, or previous myocardial infarction. Rarely, these
arrhythmias may occur secondary to genetically inherited conditions
(long QT syndrome) or as uncommon "allergic
reaction" to certain medications. Treatment may be as simple
as withdrawing the offending medication, but more commonly treatment
may require coronary artery bypass surgery, angioplasty with insertion
of a coronary stent, or implantation
of a cardioverter-defibrillator.
Monomorphic
ventricular tachycardia is also classified based upon whether it
occurs in patients with structurally normal hearts or in patients
with significant heart disease, primarily cardiomyopathy coronary
artery disease, or previous myocardial infarction. Fast monomorphic
ventricular tachycardia that occurs in a patients with severe heart
disease so-called typical monomorphic
ventricular tachycardia usually requires aggressive diagnostic
studies and treatment, just as for the case of patients with polymorphic
ventricular tachycardia or ventricular fibrillation. However, patients
with normal hearts lacking heart disease who have monomorphic ventricular
tachycardia so-called atypical
monomorphic ventricular tachycardia may be safely treated
with less aggressive means, such as medical therapy or possibly
curative radiofrequency catheter ablation. These atypical monomorphic
tachycardias can be usually be diagnosed by their characteristic
ECG appearance and documentation of the absence of structural heart
disease by echocardiography. |